Cite
APA Citation
Wang, D., Robieson, W., Zhao, J., Wiener, C., & Koch, G. (2019). statistical considerations in a delayed‐start design to demonstrate disease modification effect in neurodegenerative disorders. Pharmaceutical statistics, 18, 407–419. http://access.bl.uk/ark:/81055/vdc_100086844584.0x000018